|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khorsandi SE and Heaton N: Contemporary
strategies in the management of hepatocellular carcinoma. HPB Surg.
2012:1540562012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llovet JM, Fuster J and Bruix J:
Intention-to-treat analysis of surgical treatment for early
hepatocellular carcinoma: resection versus transplantation.
Hepatology. 30:1434–1440. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Franco D, Capussotti L, Smadja C, et al:
Resection of hepatocellular carcinomas. Results in 72 European
patients with cirrhosis. Gastroenterology. 98:733–738.
1990.PubMed/NCBI
|
|
7
|
Schwartz M, Roayaie S and Konstadoulakis
M: Strategies for the management of hepatocellular carcinoma. Nat
Clin Pract Oncol. 4:424–432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rajagopalan H and Lengauer C: Aneuploidy
and cancer. Nature. 432:338–341. 2004. View Article : Google Scholar
|
|
9
|
Ricke RM and van Deursen JM: Aneuploidy in
health, disease, and aging. J Cell Biol. 201:11–21. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cimini D and Degrassi F: Aneuploidy: a
matter of bad connections. Trends Cell Biol. 15:442–451. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bakhoum SF and Compton DA: Chromosomal
instability and cancer: a complex relationship with therapeutic
potential. J Clin Invest. 122:1138–1143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang QJ, Lu XF, Cheng XL, et al: The
active expression of CenpB, a constitutive protein in the
centromeres of chromosomes, in breast cancer tissues. Yi Chuan Xue
Bao. 31:236–240. 2004.(In Chinese).
|
|
13
|
Sugata N, Munekata E and Todokoro K:
Characterization of a novel kinetochore protein, CENP-H. J Biol
Chem. 274:27343–27346. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuen KW, Montpetit B and Hieter P: The
kinetochore and cancer: what’s the connection? Curr Opin Cell Biol.
17:576–582. 2005.
|
|
15
|
Bakhoum SF and Compton DA: Kinetochores
and disease: keeping microtubule dynamics in check! Curr Opin Cell
Biol. 24:64–70. 2012.PubMed/NCBI
|
|
16
|
Kramer A, Neben K and Ho A: Centrosome
replication, genomic instability and cancer. Leukemia. 16:767–775.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fukagawa T, Mikami Y, Nishihashi A, et al:
CENP-H, a constitutive centromere component, is required for
centromere targeting of CENP-C in vertebrate cells. EMBO J.
20:4603–4617. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sugata N, Li S, Earnshaw WC, et al: Human
CENP-H multimers colocalize with CENP-A and CENP-C at active
centromere - kinetochore complexes. Hum Mol Genet. 9:2919–2926.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liao WT, Wang X, Xu LH, et al: Centromere
protein H is a novel prognostic marker for human nonsmall cell lung
cancer progression and overall patient survival. Cancer.
115:1507–1517. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao WT, Song LB, Zhang HZ, et al:
Centromere protein H is a novel prognostic marker for
nasopharyngeal carcinoma progression and overall patient survival.
Clin Cancer Res. 13:508–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo XZ, Zhang G, Wang JY, et al:
Prognostic relevance of Centromere protein H expression in
esophageal carcinoma. BMC Cancer. 8:2332008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao WT, Yu CP, Wu DH, et al: Upregulation
of CENP-H in tongue cancer correlates with poor prognosis and
progression. J Exp Clin Cancer Res. 28:742009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shigeishi H, Higashikawa K, Ono S, et al:
Increased expression of CENP-H gene in human oral squamous cell
carcinomas harboring high-proliferative activity. Oncol Rep.
16:1071–1075. 2006.PubMed/NCBI
|
|
24
|
Orthaus S, Ohndorf S and Diekmann S: RNAi
knockdown of human kinetochore protein CENP-H. Biochem Biophys Res
Commun. 348:36–46. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tomonaga T, Matsushita K and Ishibashi M:
Centromere protein H is up-regulated in primary human colorectal
cancer and its overexpression induces aneuploidy. Cancer Res.
65:4683–4689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hamilton SR and Aaltonen LA: World Health
Organization Classification of Tumors: Pathology and Genetics of
Tumours of the Digestive System. LARC Press; Lyon: 2000
|
|
27
|
Sobin LH and Fleming ID: TNM
Classification of Malignant Tumors, fifth edition (1997). Union
Internationale Contrele Cancer and the American Joint Committee on
Cancer. Cancer. 80:1803–1804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cleveland DW, Mao Y and Sullivan KF:
Centromeres and kinetochores: from epigenetics to mitotic
checkpoint signaling. Cell. 112:407–421. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schmidt JC, Arthanari H and Boeszoermenyi
A: The kinetochore-bound Ska1 complex tracks depolymerizing
microtubules and binds to curved protofilaments. Dev Cell.
23:968–980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kops GJ, Weaver BA and Cleveland DW: On
the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev
Cancer. 5:773–785. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tomonaga T, Matsushita K, Yamaguchi S, et
al: Overexpression and mistargeting of centromere protein-A in
human primary colorectal cancer. Cancer Res. 63:3511–3516.
2003.PubMed/NCBI
|
|
32
|
Li Y, Zhu Z, Zhang S, et al:
ShRNA-targeted centromere protein A inhibits hepatocellular
carcinoma growth. PLoS One. 6:e177942011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McGovern SL, Qi Y, Pusztai L, et al:
Centromere protein-A, an essential centromere protein, is a
prognostic marker for relapse in estrogen receptor-positive breast
cancer. Breast Cancer Res. 14:R722012. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Q, Qian YM, Zhao XL, et al: Expression
and prognostic significance of centromere protein A in human lung
adenocarcinoma. Lung Cancer. 77:407–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wood KW, Lad L, Luo L, et al: Antitumor
activity of an allosteric inhibitor of centromere-associated
protein-E. Proc Natl Acad Sci USA. 107:5839–5844. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
O’Brien SL, Fagan A, Fox EJ, et al: CENP-F
expression is associated with poor prognosis and chromosomal
instability in patients with primary breast cancer. Int J Cancer.
120:1434–1443. 2007.PubMed/NCBI
|
|
37
|
Shigeishi H, Mizuta K, Higashikawa K, et
al: Correlation of CENP-F gene expression with tumor-proliferating
activity in human salivary gland tumors. Oral Oncol. 41:716–722.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barbanis S, Ioannou M, Kouvaras E, et al:
INCENP (inner centromere protein) is overexpressed in high grade
non-Hodgkin B-cell lymphomas. Pathol Oncol Res. 15:11–17. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nakajima T, Moriguchi M, Mitsumoto Y, et
al: Centrosome aberration accompanied with p53 mutation can induce
genetic instability in hepatocellular carcinoma. Mod Pathol.
17:722–727. 2004. View Article : Google Scholar : PubMed/NCBI
|
